What other stocks do shareholders of Transition Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Transition Therapeutics investors own include Telaria (TLRA) , Himax Technologies (HIMX) , Link Motion (LKM) , Petróleo Brasileiro S.A. - Petrobras (PBR) , Achillion Pharmaceuticals (ACHN) , AcelRx Pharmaceuticals (ACRX) , Acacia Research (ACTG) , AK Steel (AKS) , ALU (ALU) and Ambarella (AMBA) .

NASDAQ:TTHI

Transition Therapeutics (TTHI) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free TTHI Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $1.52
▼
$1.52
50-Day Range: N/A
52-Week Range: $0.66
▼
$2.75

Volume: N/A
Average Volume: 70,238 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Transition Therapeutics alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Transition Therapeutics Stock (NASDAQ:TTHI)

Transition Therapeutics Inc. is a product-focused biopharmaceutical company. The Company's principal business activity is the researching and developing of therapeutic agents. The Company is developing therapeutics for central nervous system (CNS) and metabolic disease indications. The Company's technologies are focused on the treatment of agitation and aggression in Alzheimer's disease and diabetes. The Company's subsidiary, Transition Therapeutics Ireland Limited (Transition Ireland), is developing two drug candidates: neuropsychiatric candidate ELND005 and androgen deficiency candidate TT701. The Company's subsidiary, Waratah Pharmaceuticals Inc. (Waratah), is developing diabetes drug candidate TT401. The Company's other two entities provide development services in support of the clinical and non-clinical activities of Transition Ireland and Waratah.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

TTHI Stock News Headlines

February 7, 2024 | ca.finance.yahoo.com

Ackman exits Lowe's after bet earned $1.3 billion for Pershing Square funds

December 5, 2023 | markets.businessinsider.com

Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

September 17, 2023 | foxnews.com

School hid teen's gender transition from parents, leading to runaway, abuse nightmare: lawsuit

May 31, 2023 | tmcnet.com

TG Therapeutics Announces Data from the ULTIMATE I

January 21, 2023 | thestreet.com

Transition Therapeutics to Pay Eli Lilly $1M

September 19, 2022 | benzinga.com

Tryp Therapeutics Appoints Jim O'Neill as Chief Financial Officer

September 14, 2022 | yahoo.com

Global Anti-Drone Market Report 2022: Development of Versatile and Scalable Anti-Drone Systems Presents Opportunities

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

September 7, 2022 | finance.yahoo.com

CytoImmune Therapeutics Appoints Remus Vezan, M.D., Ph.D., as Chief Medical Officer

August 26, 2022 | nz.finance.yahoo.com

Wugen Appoints Natalie Mount, Ph.D., as Chair of the Board of Directors

May 20, 2022 | yahoo.com

Ocean County Prosecutor's Office takes over Lavallette Police Department

April 4, 2022 | ca.finance.yahoo.com

US to end policy expelling migrants over Covid

March 11, 2022 | lse.co.uk

Challenger Energy appoints Trinidadian as new country head

March 10, 2022 | yahoo.com

Zoë Kravitz Says Previous 'Batman' Movie Rejected Her As Too 'Urban'

March 10, 2022 | yahoo.com

Award-Winning Actor Scarlett Johansson Joins Dress for Success® Worldwide as Global Ambassador as it celebrates its 25th Anniversary

February 3, 2022 | nz.finance.yahoo.com

Kvarta SIA, subsidiary of Hepsor AS in Latvia, signs 7.5 m€ loan agreement to finance the construction of development project

January 14, 2022 | thestreet.com

Transition Stock Gaps Up On Today's Open (TTHI)

December 18, 2021 | ca.finance.yahoo.com

New Mask Rules In Malibu As State Mandate Returns

November 10, 2021 | nz.finance.yahoo.com

The Benchmark Company Achieves Significant Milestone of 20 Senior Analysts and Will Expand Coverage to Over 350 Companies

November 5, 2021 | nz.finance.yahoo.com

EducationSuperHighway Study Reveals 18 Million American Households Have Access to the Internet But Can’t Afford to Connect

November 5, 2021 | au.finance.yahoo.com

Liquidia Reports Third Quarter 2021 Financial Results and Provides Corporate Update

November 5, 2021 | nz.finance.yahoo.com

Biden To Parents With Kids 5 And Over: ‘Please Get Them Vaccinated’

November 4, 2021 | au.finance.yahoo.com

CareDx Completes Orderly Management Transition

November 4, 2021 | ca.finance.yahoo.com

GZ6G Technologies Hires Helen Young as Director of Operations and IT Wireless Managed Network Services

November 4, 2021 | sg.finance.yahoo.com

Ivy Brain Tumor Center Collaborates with GSK on New Phase 0 Clinical Trial to Evaluate Niraparib in Patients with Brain Cancer

November 4, 2021 | nz.finance.yahoo.com

Bazaarvoice names Zarina Lam Stanford as Chief Marketing Officer to drive market education and adoption of user-generated content

See More Headlines

Receive TTHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Transition Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:TTHI
CUSIP: N/A
CIK: 1399250
Web: www.transitiontherapeutics.com
Phone: +1-416-2607770
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

TTHI Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Transition Therapeutics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Transition Therapeutics investors own include Telaria (TLRA), Himax Technologies (HIMX), Link Motion (LKM), Petróleo Brasileiro S.A. - Petrobras (PBR), Achillion Pharmaceuticals (ACHN), AcelRx Pharmaceuticals (ACRX), Acacia Research (ACTG), AK Steel (AKS), ALU (ALU) and Ambarella (AMBA).

This page (NASDAQ:TTHI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Transition Therapeutics (TTHI) Stock Price, News & Analysis

About Transition Therapeutics Stock (NASDAQ:TTHI)

TTHI Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

TTHI Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info